Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Exploring gene expression signatures for predicting disease free survival after resection of colorectal cancer liver metastases.

Snoeren N, van Hooff SR, Adam R, van Hillegersberg R, Voest EE, Guettier C, van Diest PJ, Nijkamp MW, Brok MO, van Leenen D, Koerkamp MJ, Holstege FC, Rinkes IH.

PLoS One. 2012;7(11):e49442. doi: 10.1371/journal.pone.0049442. Epub 2012 Nov 21.

2.

Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling.

Lim HY, Sohn I, Deng S, Lee J, Jung SH, Mao M, Xu J, Wang K, Shi S, Joh JW, Choi YL, Park CK.

Ann Surg Oncol. 2013 Nov;20(12):3747-53. doi: 10.1245/s10434-013-3070-y. Epub 2013 Jun 26.

PMID:
23800896
3.

Hepatic pedicle clamping during hepatic resection for colorectal liver metastases: no impact on survival or hepatic recurrence.

Weiss MJ, Ito H, Araujo RL, Zabor EC, Gonen M, D'Angelica MI, Allen PJ, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR.

Ann Surg Oncol. 2013 Jan;20(1):285-94. doi: 10.1245/s10434-012-2583-0. Epub 2012 Aug 7.

PMID:
22868921
4.

CXCR4 expression predicts patient outcome and recurrence patterns after hepatic resection for colorectal liver metastases.

Yopp AC, Shia J, Butte JM, Allen PJ, Fong Y, Jarnagin WR, DeMatteo RP, D'Angelica MI.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S339-46. doi: 10.1245/s10434-011-1774-4. Epub 2011 May 17.

PMID:
21584832
5.
6.

Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival.

Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, Giacchetti S, Paule B, Kunstlinger F, Ghémard O, Levi F, Bismuth H.

Ann Surg. 2004 Oct;240(4):644-57; discussion 657-8.

7.

Gene expression profiles accurately predict outcome following liver resection in patients with metastatic colorectal cancer.

Ito H, Mo Q, Qin LX, Viale A, Maithel SK, Maker AV, Shia J, Kingham P, Allen P, DeMatteo RP, Fong Y, Jarnagin WR, D'Angelica M.

PLoS One. 2013 Dec 10;8(12):e81680. doi: 10.1371/journal.pone.0081680. eCollection 2013.

8.

Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer.

Ito H, Are C, Gonen M, D'Angelica M, Dematteo RP, Kemeny NE, Fong Y, Blumgart LH, Jarnagin WR.

Ann Surg. 2008 Jun;247(6):994-1002. doi: 10.1097/SLA.0b013e31816c405f.

PMID:
18520227
9.

Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer.

Lin YH, Friederichs J, Black MA, Mages J, Rosenberg R, Guilford PJ, Phillips V, Thompson-Fawcett M, Kasabov N, Toro T, Merrie AE, van Rij A, Yoon HS, McCall JL, Siewert JR, Holzmann B, Reeve AE.

Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):498-507.

10.

Gene expression profiles in esophageal adenocarcinoma predict survival after resection.

Pennathur A, Xi L, Litle VR, Gooding WE, Krasinskas A, Landreneau RJ, Godfrey TE, Luketich JD.

J Thorac Cardiovasc Surg. 2013 Feb;145(2):505-12; discussion 512-3. doi: 10.1016/j.jtcvs.2012.10.031.

11.

Significance of monocyte chemoattractant protein-1 in angiogenesis and survival in colorectal liver metastases.

Yoshidome H, Kohno H, Shida T, Kimura F, Shimizu H, Ohtsuka M, Nakatani Y, Miyazaki M.

Int J Oncol. 2009 Apr;34(4):923-30.

PMID:
19287949
12.

Clinical impact of different detection methods for disseminated tumor cells in bone marrow of patients undergoing surgical resection of colorectal liver metastases: a prospective follow-up study.

Vogelaar FJ, Mesker WE, Rijken AM, van Pelt GW, van Leeuwen AM, Tanke HJ, Tollenaar RA, Liefers GJ.

BMC Cancer. 2010 Apr 20;10:153. doi: 10.1186/1471-2407-10-153.

13.

Outcome of patients with colorectal liver metastasis: analysis of 1,613 consecutive cases.

Dexiang Z, Li R, Ye W, Haifu W, Yunshi Z, Qinghai Y, Shenyong Z, Bo X, Li L, Xiangou P, Haohao L, Lechi Y, Tianshu L, Jia F, Xinyu Q, Jianmin X.

Ann Surg Oncol. 2012 Sep;19(9):2860-8. doi: 10.1245/s10434-012-2356-9. Epub 2012 Apr 12.

PMID:
22526903
14.

Correlation between postoperative infective complications and long-term outcomes after hepatic resection for colorectal liver metastasis.

Farid SG, Aldouri A, Morris-Stiff G, Khan AZ, Toogood GJ, Lodge JP, Prasad KR.

Ann Surg. 2010 Jan;251(1):91-100. doi: 10.1097/SLA.0b013e3181bfda3c.

PMID:
19858702
15.

Expression profiling identifies genes that predict recurrence of breast cancer after adjuvant CMF-based chemotherapy.

Specht K, Harbeck N, Smida J, Annecke K, Reich U, Naehrig J, Langer R, Mages J, Busch R, Kruse E, Klein-Hitpass L, Schmitt M, Kiechle M, Hoefler H.

Breast Cancer Res Treat. 2009 Nov;118(1):45-56. doi: 10.1007/s10549-008-0207-y. Epub 2008 Oct 17.

PMID:
18925433
16.

Survival of patients operated for colorectal liver metastases and concomitant extra-hepatic disease: external validation of a prognostic model.

Mavros MN, Hyder O, Pulitano C, Aldrighetti L, Pawlik TM.

J Surg Oncol. 2013 Apr;107(5):481-5. doi: 10.1002/jso.23260. Epub 2012 Sep 5.

PMID:
22952157
17.

Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients.

Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG.

Ann Surg. 2008 Jan;247(1):125-35.

PMID:
18156932
18.

Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer.

Arango D, Laiho P, Kokko A, Alhopuro P, Sammalkorpi H, Salovaara R, Nicorici D, Hautaniemi S, Alazzouzi H, Mecklin JP, Järvinen H, Hemminki A, Astola J, Schwartz S Jr, Aaltonen LA.

Gastroenterology. 2005 Sep;129(3):874-84.

PMID:
16143127
19.

P53 overexpression in colorectal metastases confined to the liver and outcome of liver resection.

Heisterkamp J, van Bommel J, Hop WC, Tilanus HW, Zondervan PE, IJzermans JN.

Hepatogastroenterology. 1999 Nov-Dec;46(30):3109-14.

PMID:
10626170
20.

Prognostic scoring in colorectal cancer liver metastases: development and validation.

Schindl M, Wigmore SJ, Currie EJ, Laengle F, Garden OJ.

Arch Surg. 2005 Feb;140(2):183-9.

PMID:
15724001

Supplemental Content

Support Center